Form 4: MapLight Therapeutics Insider Sells Shares
Statement of Changes in Beneficial Ownership
Anatol Kreitzer, Chief Discovery Officer at MapLight Therapeutics, sold a significant number of shares under a Rule 10b5-1 trading plan.
Summary
- Anatol Kreitzer, Chief Discovery Officer at MapLight Therapeutics, Inc. (MPLT), reported the sale of 45,397 shares of common stock on April 27, 2026.
- These sales were executed under a Rule 10b5-1 trading plan adopted on December 24, 2025.
- The total value of the sales is not explicitly stated but involved transactions at weighted average prices ranging from $28.27 to $30.64.
- Following these transactions, Kreitzer beneficially owns 211,190 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. While it involves an insider selling shares, the transaction was conducted under a pre-arranged Rule 10b5-1 plan, mitigating concerns about opportunistic trading.
Negatives
- Insider selling can sometimes be perceived negatively by the market, although in this case, it was conducted under a pre-established trading plan.
Future Outlook
No specific future outlook or guidance is provided in this filing, as it pertains to insider stock transactions.
Industry Context
StockSavvy.ai notes that insider sales under Rule 10b5-1 plans are common and are designed to provide an affirmative defense against allegations of insider trading. This filing indicates a planned divestment by a key executive, which is a routine event for many public companies.
Stakeholder Impact
- Shareholders: The sale of shares by an executive may be monitored, but the use of a Rule 10b5-1 plan suggests a pre-determined strategy rather than a reaction to non-public information.
Key Dates
| Date | Description |
|---|---|
| 12/24/2025 | Date Rule 10b5-1 trading plan was adopted by Reporting Person. |
| 04/27/2026 | Transaction Date for the sale of common stock. |
| 04/29/2026 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
MapLight Therapeutics, MPLT, Form 4, Insider Trading, Rule 10b5-1, Stock Sale, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.